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Viewpoint
Alcohol Septal Ablation Versus Myectomy
There is an ongoing debate as to the preferred treatmentmodality for patients withmedically refractory, symptomatic, obstructive hypertrophic cardiomyopathy
(HCM).Whereas both alcohol septal ablation (ASA) and surgicalmyectomyoffer high
initial success rates, there is less long-term outcome data for alcohol ablation. This
suggests the need for a randomized trial.Olivotto and colleagues argue that the logistics
of such a trial may be insurmountable; given the rarity of the disease and the high rates
of procedural success with both techniques, more than 34,000 cases would need to be
screened to have adequate power for the trial. See page 831. See figure.
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Metabolic Syndrome
Cholesterol Lowering Improves Inflammatory Markers in Patients With RA
Some studies have suggested that statins can improve markers of inflammation inpatients with rheumatoid arthritis (RA), but whether this reflects cholesterol
lowering or statin pleiotropism is unknown.Mäki-Petäjä and colleagues compared the
effects of 20 mg of simvastatin with 10 mg of ezetimibe. Both drugs significantly
reducedC-reactive protein, disease activity score, and aortic pulsewave velocity (PWV)
and improved endothelial flow-mediated dilation to similar degrees. This study dem-
onstrates that both ezetimibe and simvastatin reduce disease activity and inflammatory
markers in patients with RA, suggesting that cholesterol lowering, regardless of the
method, has anti-inflammatory effects. See page 852. See figure.
Heart Failure
Torasemide Reduces Cardiac Fibrosis More Than Furosemide
Lo´pez and colleagues have previously reported that torasemide reduces myocardialfibrosis. This study sought to understand the mechanisms for this effect and to
determine if it was a class effect. Patients were randomized to either torasemide or
furosemide and underwent serial endomyocardial biopsies. In torasemide-treated pa-
tients, both the collagen volume fraction and the activity of procollagen were reduced.
There were no changes in furosemide-treated patients. These findings suggest that the
ability of torasemide to reduce myocardial fibrosis is mediated through decreased
procollagen activation and is not a class effect of loop diuretics. See page 859.
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Heart Rhythm Disorders
Remote Magnetic Navigation for Pulmonary Vein Isolation
Recently, a novelmagnetic navigation (MN) systemhas beendeveloped that allowsthe use of a soft ablation catheter that is positioned by directionalmagnetic fields.
Di Biase and colleagues report their experience in using this system for pulmonary vein
isolation procedures. Although there was good utility in navigating the catheter to the
desired position, the ability to acheive electrical isolation was very low. These results
indicate that remote MN in the left atrium is feasible, but suggest that the 4-mm tip
catheter used for the current study is too small to achieve adequately sized lesions for
atrial fibrillation ablations. See page 868. See figure.
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Cardiac Imaging
Quantifying Atherosclerotic Inflammation With FDG-PET
Several recent studies have suggested that
18fluorodeoxyglucose positron emission
tomography (FDG-PET) imaging can be used to measure inflammation in ath-
erosclerotic plaques. Rudd and colleagues performed serial FDG-PET studies over 2
weeks to determine the variability and reproducibility of this technique, specifically
assessing inter- and intraobserver agreement and interscan variability. All measure-
ments appear to be highly reproducible. The authors conclude that FDG-PETmeets 2
important criteria for serial imaging: spontaneous changes in plaque FDG uptake are
low and interobserver agreement is high. See page 892. See figure.
